None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 19 to 80 years Patients with histologically confirmed colorectal adenocarcinoma Patients with an ECOG performance status of 0–2 Patients with a preoperative ASA physical status of I–III Patients with no prior surgical history of abdominal malignancy Patients with no history of preoperative anticoagulant use Patients who understand the study procedures and treatment plan and provide written informed consent
Exclusion criteria
Exclusion criteria: Patients with an ASA physical status of IV or higher Patients with coagulation disorders, including liver cirrhosis, end-stage renal disease, or hematologic disorders Pregnant women Patients with psychiatric disorders that make it difficult to obtain informed consent Patients with preoperative hemoglobin (Hb) levels < 7 g/dL Patients who use anticoagulants preoperatively or postoperatively Patients who undergo emergency surgery Patients who are unable to participate in outpatient follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of postoperative intra-abdominal bleeding = Clavien–Dindo grade II | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative blood loss (mL) | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital